The UK Department of Health has today announced its decisions on reform of Part IX of the Drug Tariff, following an extensive review process. See enclosed PDF.
Recommended Reading
-
The contract is awarded for products that bring improvement to the healthcare industry. Coloplast, a global medical device company and market leader in intimate healthcare, has received an Innovative...
Read More -
Announcement no. 04/2026Inside information Coloplast revises the financial guidance on organic growth and EBIT growth in constant currencies before special items for FY 2025/26, reflecting a slower...
Read More